Envista Holdings (NVST) Cash & Current Investments (2019 - 2026)
Envista Holdings (NVST) recorded quarterly Cash & Current Investments of $1.1 billion in Q2 2026, down 10.64% quarter-over-quarter from $1.2 billion in Q4 2025, and up 0.51% on a YoY basis from $1.1 billion in Q2 2025.
Envista Holdings (NVST) Cash & Current Investments (2019 - 2026) Analysis & Trends
Envista Holdings' Cash & Current Investments history runs 8 years deep, the most recent figure standing at $1.1 billion for Q2 2026.
- In Q2 2026, Cash & Current Investments rose 0.51% year-over-year to $1.1 billion; the TTM figure through Apr 2026 stood at $1.1 billion (up 0.51% YoY), while the FY2025 annual figure was $1.2 billion, up 13.34% from the prior year.
- Cash & Current Investments was $1.1 billion for Q2 2026 at Envista Holdings, down from $1.2 billion in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $1.2 billion in Q4 2025 to a low of $523.1 million in Q3 2022.
- Historically, Cash & Current Investments has averaged $908.2 million across 5 years, with a median of $991.3 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments surged 144.4% in 2022, then slumped 45.73% in 2023.
- A 5-year view of Cash & Current Investments shows it stood at $606.9 million in 2022, then jumped by 54.89% to $940.0 million in 2023, then advanced by 13.73% to $1.1 billion in 2024, then gained by 13.34% to $1.2 billion in 2025, then decreased by 10.64% to $1.1 billion in 2026.
- The last three Cash & Current Investments figures came in at $1.1 billion (Q2 2026), $1.2 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 4.52 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.24 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.02 Bn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.21 Bn |
| Sep 26, 2025 | 1.13 Bn |
| Jun 27, 2025 | 1.11 Bn |
| Mar 28, 2025 | 1.08 Bn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 27, 2024 | 991.30 Mn |
| Jun 28, 2024 | 1.04 Bn |
| Mar 29, 2024 | 948.50 Mn |
| Dec 31, 2023 | 940.00 Mn |
| Sep 29, 2023 | 824.20 Mn |
| Jun 30, 2023 | 651.70 Mn |
| Mar 31, 2023 | 585.20 Mn |
| Dec 31, 2022 | 606.90 Mn |
| Sep 30, 2022 | 568.50 Mn |
| Jul 1, 2022 | 523.10 Mn |
| Apr 1, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.07 Bn |
| Oct 1, 2021 | 638.80 Mn |
| Jul 2, 2021 | 553.90 Mn |